← Back to Search

Behavioral Intervention

Online Advance Care Planning Tool for Cognitive Impairment (Portal-Voice Trial)

N/A
Recruiting
Led By Jennifer Gabbard, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 65 years old and older
Have an active patient portal account
Must not have
Lacks decisional capacity as deemed by PCP
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months during the implementation period and up to 6 months post the implementation period
Awards & highlights

Summary

This trial aims to see if using an online tool can help improve discussions and documentation of advance care planning in people with memory problems during their regular doctor visits.

Who is the study for?
This trial is for community-dwelling adults with cognitive impairment who are under outpatient primary care. The study aims to include those who may benefit from improved discussions and documentation of their future healthcare preferences.
What is being tested?
The study is testing ACPVoice, a tool designed for advance care planning (ACP), against the standard of care in ACP. It will evaluate how well ACPVoice facilitates conversations and decision-making about future healthcare needs.
What are the potential side effects?
Since this trial involves an advance care planning tool rather than a medical treatment, traditional physical side effects are not expected. Participants may experience emotional or psychological responses when discussing sensitive end-of-life decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 65 years old or older.
Select...
I have an active account on my healthcare provider's patient portal.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My primary care doctor thinks I'm unable to make my own medical decisions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months during the implementation period and up to 6 months post the implementation period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months during the implementation period and up to 6 months post the implementation period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention Completion
Reach/Engagement
Secondary study objectives
Advance Care Planning Billing Code Usage
Advance Care Planning Documentation Rates by Primary Care Providers
Documented Designated Surrogate Decision Maker
Other study objectives
Barrier to Adoption
Digital Health Literacy
Feeling Heard and Understood
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACPVoice InterventionExperimental Treatment1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health , have a primary care physician at one of the participating sites, and have an active patient portal account.
Group II: Standard of CareActive Control1 Intervention
Community-dwelling persons living with cognitive impairment aged 65 and older with known or probable mild cognitive impairment or dementia or elevated eRADAR score (with decision-making capacity), who are affiliated with the Atrium-Wake Forest Baptist Health, have a primary care physician within the Atrium-Wake Forest Baptist Health Network, and have an active patient portal account.

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,703 Total Patients Enrolled
Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,407 Total Patients Enrolled
Jennifer Gabbard, MDPrincipal InvestigatorWake Forest University Health Sciences
2 Previous Clinical Trials
298 Total Patients Enrolled
~200 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top